Analysed BLUEJAY DIAGNOSTICS INC (BJDX:NASDAQ) News Sources
Bluejay Diagnostics and Argonaut Manufacturing Services Announce Strategic Partnership
02-06-2026
yahoo.com
Bluejay Diagnostics Announces up to $23.6 Million Private Placement Priced At-the-Market Under Nasdaq Rules
02-06-2026
yahoo.com
Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules
06-06-2026
yahoo.com
Bluejay Diagnostics Announces Successful Completion of Enrollment in the SYMON-II Multicenter Clinical Validation Study
21-07-2026
yahoo.com
Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony™ IL-6 Toward Regulatory Submission and Commercialization
13-08-2026
yahoo.com
Bluejay Diagnostics Federal Healthcare Partnership Builds Commercial Pathway Ahead of FDA Clearance
08-09-2026
advfn.com
Bluejay Diagnostics Announces SYMON-II Clinical Dataset Details Supporting Evaluation of Mortality Risk in Sepsis and Septic Shock
06-10-2026
yahoo.com
What is the current price of BLUEJAY DIAGNOSTICS INC (BJDX:NASDAQ)?
The current price of BLUEJAY DIAGNOSTICS INC (BJDX:NASDAQ) is $0.8209.
BLUEJAY DIAGNOSTICS INC (BJDX:NASDAQ) absolute price change since previous trading day?
The absolute price change of BLUEJAY DIAGNOSTICS INC (BJDX:NASDAQ) since the previous trading day is $0.0287.
BLUEJAY DIAGNOSTICS INC (BJDX:NASDAQ) percentage price change since previous trading day?
The percentage price change of BLUEJAY DIAGNOSTICS INC (BJDX:NASDAQ) since the previous trading day is 3.6228%.
What is the most recent average sentiment score for BLUEJAY DIAGNOSTICS INC (BJDX:NASDAQ)?
The most recent average sentiment score for BLUEJAY DIAGNOSTICS INC (BJDX:NASDAQ) is 74 out of 100.
What is the most recent average sentiment for BLUEJAY DIAGNOSTICS INC (BJDX:NASDAQ)?
The most recent sentiment for BLUEJAY DIAGNOSTICS INC (BJDX:NASDAQ) is .
SEC-8K** Filing Available For BLUEJAY DIAGNOSTICS INC (BJDX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.